Journal Article Summary

The article investigates the side effects associated with different preventive pharmacologic therapies (PPT) for kidney stone disease, specifically focusing on alkali citrate, thiazides, and allopurinol. This topic is significant because kidney stone disease is a chronic condition that can lead to recurrent stone events, affecting a substantial number of individuals. Understanding the side effects of these medications is crucial for both patients and healthcare providers, as it can influence treatment adherence and overall health outcomes.

The study utilized claims data from working-age adults diagnosed with kidney stone disease between 2008 and 2019. Researchers identified patients who received prescriptions for alkali citrate, thiazides, or allopurinol and tracked the occurrence of various side effects over two years. The findings revealed that thiazides were linked to the highest rates of side effects, including hypokalemia and hyperglycemia/diabetes, compared to the other medications. In contrast, alkali citrate and allopurinol had lower rates of these specific side effects, although allopurinol was associated with a higher risk of hyperglycemia/diabetes when compared to alkali citrate.

Despite its valuable insights, the study has limitations, such as potential missing data and the inability to capture detailed laboratory values that could better inform risk assessments for side effects. Patients should discuss these findings with their healthcare providers, particularly regarding the need for regular monitoring of metabolic side effects while on PPT. Understanding the risks associated with these medications can help patients make informed decisions about their treatment options and improve adherence to prescribed therapies.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Hsi Ryan S., Crivelli Joseph J., Yan Phyllis L., Shahinian Vahakn, Hollingsworth John M.. Comparison of class-specific side effects across preventative pharmacologic therapies for kidney stone disease. Urology practice 2024. DOI: 10.1097/UPJ.0000000000000470. PMID: 38117963. PMCID: PMC10751065.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]